China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
1.610
+0.010 (0.63%)
At close: Feb 20, 2026
Market Cap3.97B +85.8%
Revenue (ttm)934.24M +12.1%
Net Income196.19M +18.7%
EPS0.08 +20.1%
Shares Outn/a
PE Ratio20.25
Forward PE17.55
Dividend0.03 (2.06%)
Ex-Dividend DateAug 29, 2025
Volumen/a
Average Volume79
Open1.620
Previous Close1.600
Day's Range1.610 - 1.620
52-Week Range0.805 - 1.650
Betan/a
RSI60.31
Earnings DateMar 16, 2026

About FRA:2M7C

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Sector Healthcare
Founded 1995
Employees 6,095
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements